Ardelyx | ARDX - Current Assets

Stock Price
7.74
Daily Change
-0.05 -0.64%
Monthly
27.09%
Yearly
40.22%
Q1 Forecast
7.45

Ardelyx reported $367.98M in Current Assets for its fiscal quarter ending in September of 2025.





Current Assets Change Date
Abbott USD 24.84B 371M Sep/2025
Amgen USD 27.88B 1.15B Sep/2025
Ardelyx USD 367.98M 16.42M Sep/2025
aTyr Pharma USD 93.01M 5.52M Sep/2025
Corcept Therapeutics USD 541.13M 98.02M Sep/2025
Sanofi EUR 30.95B 8.99B Dec/2025
TG Therapeutics USD 599.76M 64.2M Sep/2025
United Therapeutics USD 3.49B 332.9M Sep/2025